These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7989403)

  • 1. Pharmacokinetics of phenytoin in routine clinic patients in Malaysia.
    Ismail R; Rahman AF; Chand P
    J Clin Pharm Ther; 1994 Aug; 19(4):245-8. PubMed ID: 7989403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Michaelis-Menten pharmacokinetics of phenytoin in adult Malaysian patients.
    Ismail R; Rahman AF
    J Clin Pharm Ther; 1990 Dec; 15(6):411-7. PubMed ID: 2089048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NONMEM approach for estimating population pharmacokinetic parameters of phenytoin in Chinese epileptics].
    Rui JZ; Cai MH; Chu XM; Chen G
    Yao Xue Xue Bao; 1995; 30(3):172-8. PubMed ID: 7639079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the population pharmacokinetic parameters of phenytoin in adult epileptic patients in South Africa.
    Valodia P; Seymour MA; Miller R; McFadyen ML; Folb PI
    Ther Drug Monit; 1999 Feb; 21(1):57-62. PubMed ID: 10051055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of phenytoin in Japanese patients with epilepsy: analysis with a dose-dependent clearance model.
    Odani A; Hashimoto Y; Takayanagi K; Otsuki Y; Koue T; Takano M; Yasuhara M; Hattori H; Furusho K; Inui K
    Biol Pharm Bull; 1996 Mar; 19(3):444-8. PubMed ID: 8924916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of population pharmacokinetic parameters of free-phenytoin in adult epileptic patients.
    Deleu D; Aarons L; Ahmed IA
    Arch Med Res; 2005; 36(1):49-53. PubMed ID: 15777995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
    Koren G; Brand N; MacLeod SM
    Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of Phenytoin Pharmacokinetic Parameters in Saudi Epileptic Patients.
    Alqahtani S; Alzaidi T; Alotaibi M; Alsultan A
    Pharmacology; 2019; 104(1-2):60-66. PubMed ID: 31067540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics of phenytoin from routine clinical data in Japan.
    Yukawa E; Higuchi S; Aoyama T
    J Clin Pharm Ther; 1989 Feb; 14(1):71-7. PubMed ID: 2921305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of phenytoin in South African black patients.
    Miller R; Rheeders M; Klein C; Suchet I
    S Afr Med J; 1987 Aug; 72(3):188-90. PubMed ID: 3603312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
    Takeuchi M; Yano I; Ito S; Sugimoto M; Yamamoto S; Yonezawa A; Ikeda A; Matsubara K
    Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of phenytoin from routine clinical data in Japan: an update.
    Yukawa E; Higuchi S; Aoyama T
    Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):1973-6. PubMed ID: 2268899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of phenytoin therapy in adults with epilepsy in the Western Cape, South Africa.
    Valodia PN; Seymour MA; Kies BM; Folb PI
    J Clin Pharm Ther; 1999 Oct; 24(5):381-5. PubMed ID: 10583702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of population pharmacokinetics for carbamazepine in Malaysian patients using the OPT computer program.
    Ismail R; Rahman AF
    J Clin Pharm Ther; 1993 Feb; 18(1):55-8. PubMed ID: 8473361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualization of phenytoin dosage regimens.
    Ludden TM; Allen JP; Valutsky WA; Vicuna AV; Nappi JM; Hoffman SF; Wallace JE; Lalka D; McNay JL
    Clin Pharmacol Ther; 1977 Mar; 21(3):287-93. PubMed ID: 837647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of pharmacokinetic interaction between grapefruit juice and phenytoin in healthy male volunteers and epileptic patients.
    Kumar N; Garg SK; Prabhakar S
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):629-32. PubMed ID: 10669910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive performance of pharmacokinetic methods for phenytoin dosing: a multi-center evaluation in 282 patients with epilepsy.
    Zaccara G; Messori A; Muscas GC; Albani F; Baruzzi A; Bianchi A; Riva R; Valenza T; Zagnoni P; Zolo P
    Epilepsy Res; 1989; 3(3):253-61. PubMed ID: 2659322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of population pharmacokinetic parameters of phenytoin using the parallel Michaelis-Menten and first-order elimination model.
    Valodia PN; Seymour MA; McFadyen ML; Miller R; Folb PI
    Ther Drug Monit; 2000 Jun; 22(3):313-9. PubMed ID: 10850399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steady-state pharmacokinetics of phenytoin from routinely collected patient data.
    Grasela TH; Sheiner LB; Rambeck B; Boenigk HE; Dunlop A; Mullen PW; Wadsworth J; Richens A; Ishizaki T; Chiba K
    Clin Pharmacokinet; 1983; 8(4):355-64. PubMed ID: 6617043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical management of therapeutic diphenylhydantoin concentrations in children.
    Smit A; Schoeman JF; Seifart HI; Parkin DP
    S Afr Med J; 1999 Oct; 89(10):1092-7. PubMed ID: 10582067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.